BIO INX
BIO INX is a Belgian spin-off from Ghent University and VUB that develops and commercializes standardized, ready-to-use bioinks and biomaterial resins for 3D bioprinting — spanning multiphoton lithography, volumetric, DLP, and extrusion printing — sold B2B to academic, pharmaceutical, and regenerative-medicine customers globally via e-commerce and distribution partners.
- Company typePrivate
- Founded2022
- HeadquartersZwijnaarde, Belgium
- Headcount1–10
- GTM typeB2B
- OfferingHardware or Manufacturing
What BIO INX does
BIO INX BV is a Belgian biomaterials company headquartered in Zwijnaarde (Ghent), founded in 2022 as a spin-off from Ghent University and the Vrije Universiteit Brussel (VUB). It develops and commercializes ready-to-use bioinks, bioink precursors and biomaterial resins used in 3D bioprinting, with a particular focus on light-based, high-resolution printing modalities — including multiphoton lithography (2PP), volumetric (tomographic) printing, digital light processing/stereolithography (DLP/SLA), and extrusion-based printing. Its portfolio includes flagship products such as GEL-MA INX X-Pure (the first GMP-like gelatin-based bioink, developed with Rousselot), READYGEL INX and READYPCL INX for volumetric bioprinting with Readily3D systems, DEGRES INX (a biodegradable, shape-memory resin enabling 4D bioprinting), BIORES INX for DLP, and a deep line of HYDROBIO INX, HYDROTECH INX, and DEGRAD INX variants for multiphoton lithography on Nanoscribe and Upnano systems. The company holds the granted CURASOL patent for UV-crosslinkable solid inks and operates under an inbound license to the foundational GelMA patent, with multiple products carrying ISO 10993-5 biocompatibility certification.
The firm's commercial model is B2B, with revenue generated from one-time unit sales of bioink kits and bioink precursors. Distribution is multi-channel: direct through the bioinx.com e-commerce platform, through major laboratory suppliers (Carl ROTH globally), and through OEM-aligned channel partners that bundle BIO INX materials with their printers (Nanoscribe, Upnano, Felix Printers, Regemat 3D, Yamato Scientific in Japan, MP Strumenti in Italy). Go-to-market is characterized as 'plug & print' — standardized, pre-optimized formulations intended to minimize end-user optimization effort and enable reproducible outcomes across printing technologies. Pricing is quote-based and not publicly disclosed.
BIO INX sells into academic and research institutions, pharmaceutical/biotech drug-discovery and animal-free testing programs, and clinical/regenerative-medicine developers. Distribution today covers Europe (HQ Belgium, plus Italy and Germany via partners), Japan, and DACH, with a global reach claim supported by Carl ROTH. The company employs 1–10 people and was founded by CEO Jasper Van Hoorick, CSO Aysu Arslan, COO Coralie Gréant, and Prof. Sandra Van Vlierberghe (co-author of the original GelMA patent). Awards include 3DNatives Startup of the Year 2023, UNIZO Starter van het Jaar 2023, and Top Biomaterials Development Company in Europe 2026.
BIO INX firmographics
Firmographics- Name
- BIO INX
- Legal name
- BIO INX BV
- Website
- https://bioinx.com
- Company type
- Private
- Founded year
- 2022
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- BIO INX is a Belgian spin-off from Ghent University and VUB that develops and commercializes standardized, ready-to-use bioinks and biomaterial resins for 3D bioprinting — spanning multiphoton lithography, volumetric, DLP, and extrusion printing — sold B2B to academic, pharmaceutical, and regenerative-medicine customers globally via e-commerce and distribution partners.
- Ownership category
- akta.pro rank
BIO INX industry classification
Industry- Product category
- 3D Bioprinting Materials
- NAICS
- Plastics Material and Resin Manufacturing (325211), Custom Compounding of Purchased Resins (325991)
- SIC
- Plastic Materials, Synth Resins & Nonvulcan Elastomers (2821), Plastic Material, Synth Resin/Rubber, Cellulos (No Glass) (2820)
- akta.pro primary industry
- 3D Bioprinting & Biofabrication (HLAAAGAC)
- akta.pro secondary industry
- Bio-based & Biodegradable Polymer Resin Manufacturing (PLA, PHA, PBS, starch blends) (IMANAAAG)
Keywords
Where BIO INX is headquartered
LocationHeadquarters
- HQ city
- Zwijnaarde
- HQ country
- Belgium
- HQ region
- Europe
Offices1 record
Markets served
BIO INX business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Technology or R&D, Operations, Supply Chain, Marketing or Sales
Revenue model
- Bioink and Biomaterial Sales: BIO INX generates revenue primarily through the sale of ready-to-use bioinks, bioink precursors, and proprietary biomaterial formulations for 3D bioprinting. Products are sold directly via their e-commerce platform and through distribution partnerships globally.
- Distribution Revenue: Products distributed through partner networks including Nanoscribe, Upnano, Felix Printers, Regemat 3D, Yamato Scientific, MP Strumenti, and Carl ROTH generate revenue through wholesale/distribution arrangements.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Unit Pricing | Pay-as-you-go | Product catalog through webshop with distribution partner access |
Go-to-market motion3 records
Distribution channels7 records
Marketing channels5 records
BIO INX product offering
Product offeringCore offering
BIO INX develops and commercializes ready-to-use bioinks, bioink precursors, and proprietary biomaterial formulations for 3D bioprinting across multiple printing modalities including multiphoton lithography (2PP), volumetric printing, DLP/stereolithography, and extrusion-based printing. The company offers a comprehensive portfolio of standardized, 'plug & print' materials spanning gelatin methacryloyl (GelMA)-based bioinks, biodegradable polyester resins, shape-memory polymers, and GMP-like formulations to support researchers and clinicians from bench to bedside.
Product overview
BIO INX is a pioneering developer of materials for 3D bioprinting, offering a comprehensive portfolio of ready-to-use bioinks and bio ink precursors for multiple printing technologies. The product portfolio includes: GEL-MA INX X-Pure (first GMP-like gelatin-based bioink for clinical translation), READYGEL INX (Gel-MA based ink for volumetric printing with Readily3D systems), DEGRES INX (shape-memory biodegradable resin for 4D bioprinting), BIORES INX (gelatin-based DLP resin), and READYPCL INX (polyester-based resin for volumetric printing). For multiphoton lithography, BIO INX offers HYDROBIO INX (cell-encapsulating bioinks in U200, N400, X400 formulations), Hydrotech INX N200 (macroscale 2PP hydrogel), HYDROTECH INX N100 (robust synthetic hydrogel), DEGRAD INX N100/U100 (biodegradable polyester resins). Additionally, BIO INX distributes X-Pure gelatin precursors in partnership with Rousselot. The company focuses on standardization and reproducibility ('plug & print' philosophy) across extrusion-based, DLP, and light-based high-resolution printing technologies.
Differentiator
Problem solved
Functional benefit
Products and services
- GEL-MA INX X-Pure First GMP-like ready-to-use gelatin-based bioink based on Rousselot's X-Pure gelatin, enabling printing constructs in the presence of living cells. Represents a significant step toward clinical translation of 3D bioprinting for tissue engineering and regenerative medicine applications.
- READYGEL INX Gel-MA based ink specifically tailored for volumetric printing. Delivered sterile and ready-to-use, with preoptimized processing parameters for high reproducibility in Readily3D's Tomolite volumetric bioprinting system. Low light dose (<600 mJ/cm²) makes it cell- and organoid-friendly.
- DEGRES INX First biodegradable and biocompatible polyester-based resin with shape memory properties for light-based (bio)printing. Can be deformed into a temporary shape after 3D printing and returns to its original printed shape when heated to body temperature (37°C), enabling 4D bioprinting. ISO 10993-5 certified biocompatible.
- BIORES INX Groundbreaking gelatin methacrylamide (GelMA)-based resin for digital light processing (DLP) bioprinting. Combines exceptional biocompatibility, ease of use, and cross-platform compatibility, eliminating challenges such as heating and water evaporation during printing.
- READYPCL INX World's first commercially available polyester-based resin for volumetric bioprinting, developed in collaboration with Readily3D for use with their Tomolite volumetric printing system. Available in 10ml and 20ml kit sizes.
- HYDROBIO INX Gelatin-based bioink enabling live cell encapsulation in multiphoton lithography/high-resolution Two-Photon Polymerization (2PP). Available in multiple formulations (U200, N400, X400) optimized for different printer systems. Water-soluble hydrogel mimicking natural cellular environment and biodegradable.
- Hydrotech INX N200 World's first hydrogel resin for Two-Photon Polymerization (2PP) enabling macroscale 3D printing (up to a few millimeters) using Nanoscribe's patented Dip-in Laser Lithography (DiLL) technology. ISO-10993-5 certified biocompatible, bio-inert, liquid, and water-soluble.
- HYDROTECH INX N100 Robust synthetic hydrogel processed in solid state using BIO INX's patented Curasol technology. After immersion in aqueous environment, forms a very robust hydrogel. Optimized for Nanoscribe systems.
- DEGRAD INX N100 First biodegradable polyester-based synthetic Two-Photon Polymerization resin. Combines biocompatibility with flexibility and easy processing thanks to Curasol technology, resulting in high feature resolutions (<500 nm).
- DEGRAD INX U100 World's first polyester-based biodegradable resin for two-photon polymerization (2PP), used in the pioneering high-resolution 3D bioprinter developed at TU Wien that achieved the fastest high-resolution 3D printer ever reported.
- X-Pure Gelatin Bioink Precursors Research and technical grade X-Pure gelatin biomaterials distributed by BIO INX in collaboration with Rousselot. Functionally equivalent to GMP-grade gelatins, helping reduce development variability and facilitate transition to clinical applications.
Quantifiable outcome
- UV-induced crosslinking in solid state occurs 5 times faster compared to molten state inks
- +2 more outcomes
Companies that use BIO INX
Customer profileNamed customers3 records
Segments3 records
Ideal customer profiles4 records
BIO INX technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration3 records
Feature8 records
BIO INX partnerships and signals
Strategic signalPartnerships
16 partnerships are on record, tiered major, core and minor.
- MP StrumentimajorOfficial distributor of BIO INX products in Italy. This collaboration marks an important step in BIO INX's continued European expansion and strengthens its presence in one of Europe's most dynamic biofabrication markets.
- Yamato ScientificmajorOfficial distributor of BIO INX products in Japan. This collaboration marks an important milestone in BIO INX's global expansion strategy and strengthens its presence in one of the world's most technologically advanced markets.
- Carl ROTHmajorDistribution partnership to expand access to 3D bioprinting solutions. Carl ROTH now offers BIO INX's entire portfolio, marking Carl ROTH's first foray into 3D bioprinting space. Partnership streamlines logistics and accelerates bioprinting advancements for researchers worldwide through Carl ROTH's established distribution network.
- PuredynecoreCollaboration to achieve unparalleled standardization and reproducibility in extrusion-based bioprinting. Puredyne contributes cutting-edge extrusion printhead technology; BIO INX provides reproducible bioinks. Partnership combines Puredyne's heated printhead module with BIO INX's Gel-MA INX inks for the Brinter One and Brinter Core bioprinting systems. Puredyne is a brand of ViscoTec Pumpen- u. Dosiertechnik GmbH based in Germany.
- AM Technologies by BrintercorePartnership with BIO INX and Puredyne to set new standards in extrusion bioprinting. AM Technologies by Brinter brings advanced bioprinter manufacturing expertise with solutions including bioprinters designed for International Space Station. Integration of Puredyne's heated printhead into Brinter One and Brinter Core systems.
- Readily3DcoreStrategic partnership to introduce new biomaterials for volumetric 3D bioprinting. First product is READYGEL INX, a state-of-the-art gel-MA based ink designed for high reproducibility and performance in tomographic printing. Readily3D develops Tomolite volumetric 3D printers. Partnership aligns with BIO INX's vision of bringing bioprinting technology to clinics.
- RousselotcoreStrategic collaboration on materials for 3D bioprinting. BIO INX distributes Rousselot's X-Pure gelatin biomaterials and introduced X-Pure version of GEL-MA INX, the first GMP-like gelatin-based bioink. Collaboration builds on 25+ year relationship; original GelMA was developed using Rousselot gelatin at Ghent University. Rousselot is a global leader in gelatin- and collagen-based solutions.
- NanoscribecoreDistribution agreement via launch of portfolio of biocompatible materials for high-resolution biofabrication. Products include HYDROBIO INX (gelatin-based bioink kit), HYDROTECH INX (synthetic hydrogel), and DEGRAD INX (biodegradable polyester-based resin). Nanoscribe is the world leader in two-photon polymerization equipment and part of the BICO Group.
- Felix PrintersminorDistribution agreement for tailored high-quality bioinks for the FELIX BIOprinter. Based on 10 years of experience in additive manufacturing, FELIXprinters developed a novel high-performance bioprinter.
- UpnanocoreLaunch of X Hydrobio INX U200, the first multiphoton lithography bioink for Upnano's NanoOne Bio-printer. Materials enable 3D printing of structures with living cells at both meso- and microscale. Upnano is a Vienna-based high-tech company, spin-out of TU Wien, focusing on high-resolution 3D-printing systems based on 2-photon polymerization.
- Regemat 3DminorDistribution partnership for deposition-based printing bioinks. Regemat 3D is an innovator in bioprinter manufacturing.
- Smart BioMaterials Consortium (SBMC)corePartnership for InCart-3D project focused on developing enabling platform technology (combination of bioink and printing process) for bone and cartilage damage. Project funded by €240,000 Interreg CrossRoads Program. SBMC is based in Eindhoven, Netherlands.
- HU3DINKS ConsortiumcoreIraSME research project developing human tissue-based bioinks for multiple 3D bioprinting technologies. Consortium includes THT Biomaterials (Vienna, Austria), Morphomed (Vienna), UpNano (Vienna), and Ludwig Boltzmann Institute for Traumatology. Belgium partners funded by VLAIO; Austria partners by FFG. Project aims for animal-free testing using human-derived materials.
- AstroCardia Project ConsortiumcoreBelgian consortium developing artificial 'heart-on-a-chip' for space-based heart ageing research. Partners include Space Applications Services, SCK CEN, QbD Group, and Antleron. BIO INX contributes bioinks for 3D bioprinting miniature hearts for the International Space Station. Project leverages accelerated ageing processes in space for cardiac research.
- Belgian Ceramic Research Center (CRIBC)minorRAPIDOS project partner focused on developing bone-specific bioresins for DLP printing. Collaboration with CERAMATHS laboratory funded by Interreg Flanders-France-Wallonia Programme.
- CERAMATHS LaboratoryminorRAPIDOS project partner alongside CRIBC and BIO INX for developing bone-specific bioresins for DLP printing.
Scale indicators2 records
Recent moves8 records
Expansion highlights6 records
BIO INX competitors and assessment
Company assessmentBroad incumbents
- Cellink (BICO Group): Cellink is the market-leading bioink and 3D bioprinting consumables brand within BICO Group. It overlaps with BIO INX across nearly all bioprinting modalities (extrusion, DLP, photopolymerization) but focuses on a broader B2C and B2B catalog including bioprinters themselves.
Direct peers
- Allevi (3D Systems): Allevi (now part of 3D Systems) develops bioinks and extrusion-based bioprinters for tissue engineering. Directly comparable to BIO INX's deposition-based ink portfolio, with similar B2B academic and pharma customer base.
- Organovo: Organovo develops 3D bioprinted human tissue models for drug discovery and disease research. Comparable to BIO INX's pharmaceutical use case (3D tissue models for drug screening) but operates further downstream as a tissue model provider.
- Aspect Biosystems: Aspect Biosystems develops bioink materials and microfluidic 3D bioprinting platforms for therapeutic discovery. Overlaps with BIO INX in bioink development and pharma/biotech customer segments.
- RegenHU: Swiss developer of bioprinters and associated bioink materials for tissue engineering and regenerative medicine. Comparable target market and product/market fit with BIO INX across extrusion and light-based modalities.
- AMSBIO: AMS Bio distributes life science research products including 3D cell culture and bioprinting materials (e.g., VitroGel, PeptiGel). Comparable to BIO INX in serving academic and pharma researchers with hydrogel/bioink reagents.
Others
- Rousselot ( Darling Ingredients): Global leader in gelatin and collagen-based solutions, and an active strategic partner of BIO INX (distributing X-Pure gelatin for the GEL-MA INX X-Pure product). Comparable as a biomaterial supplier in the life sciences space, but as an upstream/partner rather than direct competitor.
- Readily3D: Developer of Tomolite volumetric 3D bioprinters and co-development partner of BIO INX. Comparable as a bioprinting equipment supplier; sits at the equipment tier of the same value chain.
- Nanoscribe (BICO Group): World leader in two-photon polymerization (2PP) hardware and strategic distribution partner of BIO INX. Comparable as a high-resolution 3D bioprinting equipment provider; in BIO INX's value chain rather than a competitor on materials.
Emerging players
- SunP Biotech: Develops gelatin methacryloyl (GelMA) and other bioinks for bioprinting, and has been a notable academic spin-out like BIO INX. Overlaps in core GelMA-based bioink offering for academic and research customers.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights7 records
Customer concentration
BIO INX social profiles
Digital presenceBIO INX compliance and trust
Trust signalCompliance2 records
BIO INX financial estimates
Financial estimateRevenue estimate
Valuation estimate
BIO INX leadership team
Management profileNumber of profiles
Profiles6 records
BIO INX funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
BIO INX M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about BIO INX
What does BIO INX do?
BIO INX develops and commercializes ready-to-use bioinks, bioink precursors, and proprietary biomaterial formulations for 3D bioprinting across multiple printing modalities including multiphoton lithography (2PP), volumetric printing, DLP/stereolithography, and extrusion-based printing. The company offers a comprehensive portfolio of standardized, 'plug & print' materials spanning gelatin methacryloyl (GelMA)-based bioinks, biodegradable polyester resins, shape-memory polymers, and GMP-like formulations to support researchers and clinicians from bench to bedside.
Is BIO INX a public or private company?
BIO INX is a private company. It is classified as venture growth investor backed and is currently operating.
When was BIO INX founded?
BIO INX was founded in 2022. It employs 1 to 10 people.
Where is BIO INX based?
BIO INX is headquartered in Zwijnaarde, Belgium, in the Europe region.
How does BIO INX make money?
Two revenue lines are on record. Bioink and Biomaterial Sales are the primary driver. The others are distribution Revenue.
Who are BIO INX's main competitors?
Cellink (BICO Group) is listed as a broad incumbent. Direct peers are Allevi (3D Systems), Organovo, Aspect Biosystems, RegenHU and AMSBIO. Others are Rousselot ( Darling Ingredients), Readily3D and Nanoscribe (BICO Group). SunP Biotech is listed as an emerging player.
Does BIO INX have an API?
No public API is recorded for BIO INX.
What industry is BIO INX in?
BIO INX's product category is 3D Bioprinting Materials. Its primary akta.pro industry code is HLAAAGAC, 3D Bioprinting & Biofabrication, with a secondary code of IMANAAAG, Bio-based & Biodegradable Polymer Resin Manufacturing (PLA, PHA, PBS, starch blends). Its NAICS code is 325211 and its SIC code is 2821.